-
U.S. Orphan Designated Drugs Market Research Report 2025: $190 Billion Opportunities, Drugs Sales, Price, Dosage & Clinical Trials Insights to 2030 - ResearchAndMarkets.com
19 May 2025 18:48 GMT
… Orphan Drugs in Clinical Trials: > 850 Orphan Drugs
Clinical Trials Insight by Company … , is under investigation in a clinical trial for enhancing anticoagulation benefit in … .5 Amicus Therapeutics
10.6 Array BioPharma
10.7 Astellas Pharma
10 …
-
Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight
20 Sep 2024 17:00 GMT
… therapies @ Squamous Cell Carcinoma Clinical Trials Squamous Cell Carcinoma Therapeutics Assessment …
5.
Squamous Cell Carcinoma Clinical Trial Therapeutics
6.
Squamous Cell … Group Co., Ltd., Novartis, Array BioPharma, among others. Basal Cell Carcinoma …
-
Uveal Melanoma Treatment Market Set For Major Transformation Through 2034 Fueled By Targeted Therapies And Rising Awareness Delveinsight
30 Jul 2025 00:02 GMT
… Sciences, Inc., Bristol Myers Squibb, Array BioPharma, Janssen, Ono Pharmaceutical, AstraZeneca, Roche … reports integrate real-world data, clinical trial findings, and expert interviews to …
-
Brain Metastasis from Breast Cancer Pipeline Analysis 2024 Clinical Trials, FDA, EMA, PMDA Approvals, Emerging Therapies
09 Jul 2024 16:54 GMT
… Myers Squibb, Bayer, Northwest Biotherapeutics, Array BioPharma, and others.
• Promising Brain … Metastasis from Breast Cancer in clinical trials @ Brain Metastasis from … Brain Metastasis from Breast Cancer Clinical Trials
Brain Metastasis from Breast …
-
Bladder Cancer Treatment Market 2032: FDA Approvals, Clinical Trials, Therapies and Companies by DelveInsight
09 Jul 2024 12:30 GMT
Bladder cancer companies are Pfizer, Celgene, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GSK, Sanofi, Roche, Novartis, Johnson & Johnson, Merck, more
ALBANY, NEW YORK, UNITED STATES, July 9, 2024 /EINPresswire.com/ -- DelveInsight's …
-
Global KRAS Inhibitors Market & Clinical Trials Future Market Outlook 2030: A $600 Million Market Opportunity by 2030 - ResearchAndMarkets.com
24 Jun 2024 12:47 GMT
… in Clinical Trials > 90 Drugs
Global KRAS Inhibitor Clinical Trials Insight …
9. Marketed KRAS Inhibitor Clinical Trials Insight by Country, Company … AnBogen Therapeutics
Applied Pharmaceutical Science
Array BioPharma (Pfizer)
Ascentage Pharma
…
-
Antibody-Drug Conjugates In Oncology Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, And Companies By Delveinsight
07 Jun 2024 12:27 GMT
… -drug conjugates in oncology clinical trials, with over 30 major … , Eucure Biopharma, PharmaEngine, Vernalis, Array BioPharma, Genentech, Boehringer Ingelheim, Sentinel Oncology … Antibody-drug Conjugates in Oncology Clinical Trial Therapeutics
6. Antibody-drug …
-
Brain Metastasis From Breast Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals, Emerging Therapies, And Growth Prospects
05 Jun 2024 01:03 GMT
… Squibb, Bayer, Northwest Biotherapeutics, Array BioPharma, and others.
Promising Brain Metastasis … Metastasis from Breast Cancer in clinical trials @ Brain Metastasis from … Brain Metastasis from Breast Cancer Clinical Trials
Brain Metastasis from Breast …
-
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain
21 Mar 2024 17:00 GMT
… ) -- PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight … inhibitors @ PI3K Inhibitors Clinical Trials PI3K Inhibitors Therapeutics … Eucure Biopharma, PharmaEngine, Vernalis, Array BioPharma, Genentech, Boehringer Ingelheim, Sentinel …
-
HDAC Inhibitor Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
08 Jan 2024 18:00 GMT
… inhibitor @ HDAC Inhibitor Clinical Trials HDAC Inhibitor Therapeutics Assessment … Assessment
5.
HDAC Inhibitor Clinical Trial Therapeutics
6.
HDAC … Eucure Biopharma, PharmaEngine, Vernalis, Array BioPharma, Genentech, Boehringer Ingelheim, Sentinel …
About
© 1995-2025